← FDA Drug Approvals (Drugs@FDA)

PYLARIFY

NDA · New Drug Application · Sponsor: PROGENICS PHARMS INC · Approved 2021-05-26

Drug application

FDA Application #

NDA214793

Application type

New Drug Application

Brand name

PYLARIFY

Generic name

PIFLUFOLASTAT F-18

Active ingredients

PIFLUFOLASTAT F-18

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

PROGENICS PHARMS INC

Manufacturer

Progenics Pharmaceuticals, Inc.

First approval

2021-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown